ZetrOZ Systems | WebDisclosure

Switch to English

10702	Sociétés
228922	Mots-clés
157518	Articles
121519	Communiqués

Accueil
Sociétés
ZetrOZ Systems

COMMUNIQUÉ DE PRESSE

publié le 01/12/2023 à 18:45, il y a 2 années 7 mois

ZetrOZ Systems Partners with Military Sports Medicine Providers Delivering Advanced Healing Technologies
ZetrOZ Systems will showcase its sam® wearable ultrasound unit at SOMOS 2023 to demonstrate the proven ability of sustained acoustic medicine technology to speed soft tissue healing, reducing the need for surgery and opioids

ZetrOZ Systems Sustained Acoustic Medicine Technology Soft Tissue Healing Sam® Wearable Ultrasound SOMOS 2023
COMMUNIQUÉ DE PRESSE

publié le 21/11/2023 à 15:00, il y a 2 années 7 mois

With Injuries Rising Late in Football Season, ZetrOZ Systems’ Sustained Acoustic Medicine Provides Recovery Option
COMMUNIQUÉ DE PRESSE

publié le 19/10/2023 à 17:30, il y a 2 années 8 mois

Athletes Heal Better, Return to Play Sooner With ZetrOZ Systems’ sam Ultrasound Treatment and PRP Than With PRP Alone
COMMUNIQUÉ DE PRESSE

publié le 14/09/2023 à 15:00, il y a 2 années 9 mois

ZetrOZ Systems' sam Technology Can Help College Athletes Recover From Injury
COMMUNIQUÉ DE PRESSE

publié le 07/09/2023 à 15:00, il y a 2 années 10 mois

As Football Season Kicks Off, ZetrOZ Systems Can Aid Injury Healing
COMMUNIQUÉ DE PRESSE

publié le 09/06/2023 à 14:00, il y a 3 années 1 mois

ZetrOz Systems to Showcase sam X1 at TOBI Conference
COMMUNIQUÉ DE PRESSE

publié le 23/05/2023 à 18:20, il y a 3 années 1 mois

Collegiate, Military and Professional Sports Medicine Experts Find sam Therapy Highly Effective
COMMUNIQUÉ DE PRESSE

publié le 23/03/2023 à 19:15, il y a 3 années 3 mois

ZetrOZ to Showcase sam Medical Technology at the RMATA 2023 Annual Clinical Symposium
COMMUNIQUÉ DE PRESSE

publié le 21/03/2023 à 13:00, il y a 3 années 3 mois

ZetrOZ Systems to Demonstrate Injury-Healing sam 2.0 and sam x1 Units at the Professional Football Athletic Trainer's Society Membership Presentation March 21
COMMUNIQUÉ DE PRESSE

publié le 08/03/2023 à 16:30, il y a 3 années 4 mois

ZetrOZ Systems to Showcase Sustained Acoustic Medicine sam 2.0 and sam X1 Units at the American Academy of Orthopedic Surgeons 2023 Annual Meeting

Les Echos

Publié le 09/07/2026 à 13:56, il y a 37 minutes

Statement of transactions in own shares from July 6, 2026 to July 8, 2026
Publié le 09/07/2026 à 13:56, il y a 37 minutes

Déclaration des transactions sur actions propres réalisées du 06/07/2026 au 08/07/2026
Publié le 09/07/2026 à 07:30, il y a 7 heures 4 minutes

Half-year liquidity contract statement June 30, 2026
Publié le 09/07/2026 à 07:30, il y a 7 heures 4 minutes

Half-year liquidity contract statement June 30, 2026
Publié le 09/07/2026 à 07:30, il y a 7 heures 4 minutes

Bilan semestriel - 30 juin 2026

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 09/07/2026 à 14:00, il y a 34 minutes

Mise à jour de l'entreprise
Publié le 09/07/2026 à 14:00, il y a 34 minutes

Corporate Update
Publié le 09/07/2026 à 14:00, il y a 34 minutes

GameSquare Signs Dairy MAX as Brand Partner for the World of Dance
Publié le 09/07/2026 à 14:00, il y a 34 minutes

Horizon Aircraft Selects BETA Technologies Advanced Flight Control Computers and Software for the Cavorite X7
Publié le 09/07/2026 à 14:00, il y a 34 minutes

Loop Industries Announces Date for First Quarter Fiscal 2027 Financial Results and Conference Call

Voir tout ACCESSWIRE

EQS Group

Publié le 09/07/2026 à 14:05, il y a 28 minutes

DJI Puts Drones to the Test on the World's Highest Peak, Advancing Critical High-Altitude Delivery, Mapping, and Climate Research Applications
Publié le 09/07/2026 à 12:35, il y a 1 heure 58 minutes

Cognizant to scale to 5,000 Frontier Certified Engineers and 10,000 Frontier Business Operators
Publié le 09/07/2026 à 12:34, il y a 2 heures

Amundi Physical Metals plc: Final Terms
Publié le 09/07/2026 à 12:30, il y a 2 heures 4 minutes

Immunic to Participate in Investor Conferences in July
Publié le 09/07/2026 à 12:16, il y a 2 heures 17 minutes

Phase III GRAPPA trial supports ATLG (Grafalon®) as standard of care in matched unrelated donor stem cell transplantation